| Home | E-Submission | Sitemap | Contact Us |  
The Korean Journal of Medicine 2007;73(6): 643-646.
증례 : 말단비대증 환자에서 임상 호전을 보인 1예
이영주&#;조현철&#;하승형&#;장지원&#;김종화&#;황흥곤, Hyun Chul Jo, Seung Hyung Ha, Ji Wong Jang, Jong Hwa Kim, Heung Kon Hwang
Acromegaly improved with sandostatin LAR treatment
Young Ju Lee, Hyun Chul Jo, Seung Hyung Ha, Ji Wong Jang, Jong Hwa Kim, Heung Kon Hwang
Cardiology Division, Department of Internal Medicine, Yeungnam University Hospital1
Cardiovascular disease is the most frequent cause of death in patients with acromegaly. Recently, long-term treatment with a somatostatin analogue (Sandostatin LAR) has been shown to be effective in controlling growth hormone (GH) and insulin like growth factor-1 (IGF-1) hypersecretion in most patients with acromegaly. Along with the effectiveness in the hormone profile, Sandostatin LAR has been reported to be effective for tumor mass shrinkage and clinical symptom improvement. We have encountered a female acromeglic patient with severe dilated cardiomyopathy and the patient was treated with Sandostatin LAR After treatment for 12 months, as seen by follow up echocardiography, the overall cardiac function was significantly improved. We report the case with a review of the literature. (Korean J Med 73:643-646, 2007)
Keywords: Acromegaly, Dilated cardiomyopathy
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplementary Material  Supplementary Material
A case of omental infarction successfully managed with conservative treatment  2009 August;77(1)
Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791   Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association of Internal Medicine. All rights reserved.                powerd by m2community